Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
UBS
McKesson
Fuji
Cerilliant
Covington
QuintilesIMS
Deloitte

Generated: May 22, 2018

DrugPatentWatch Database Preview

DILT-CD Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Dilt-cd patents expire, and when can generic versions of Dilt-cd launch?

Dilt-cd is a drug marketed by Apotex and is included in one NDA.

The generic ingredient in DILT-CD is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Summary for DILT-CD
Drug patent expirations by year for DILT-CD
Synonyms for DILT-CD
(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(+)-cis-diltiazem
(+)-diltiazem
(2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S,3S)-
42399-41-7
5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester(Diltiazem)Acetic acid
75472-92-3
8-Chloro-1-methyl-6-phenyl-4H-2,3,5,10b-tetraaza-benzo[e]azulene
AC-936
AC1L2181
AC1Q6LHX
Acalix
Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Acetic acid (S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester (Diltiazem)
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrochloride
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester(cis-(+)-Diltiazem)
Adizem
Adizem (TN)
AKOS015897257
Aldizem
Altiazem (TN)
AN-15434
Angiozem (TN)
Angizem (TN)
Angizem CD (TN)
Anoheal
API0005791
Apo-Diltiaz
BC204117
BDBM50004704
BIDD:GT0548
Bio1_000371
Bio1_000860
Bio1_001349
BPBio1_000230
BRD-K24023109-001-02-5
BRD-K24023109-003-03-9
BRN 3573079
BSPBio_000208
BSPBio_001311
C-21975
C06958
C22H26N2O4S
Cardil
Cardizem
Cardizem (Hydrochloride)
Cardizem (TN)
Cardizen LA
Cartia XT (TN)
CAS-42399-41-7
CCG-204422
CD0163
CHEBI:101278
CHEMBL23
cis-Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Citizem
CTK8F9218
D-(cis)-diltiazem
d-cis-Diltiazem
d-diltiazem
D07845
D0OB1J
DB00343
Dilacor
Dilacor-XR
Dilatam (TN)
Dilatem (TN)
Dilcardia (TN)
Dilcontin
Dilcontin SR (TN)
Dilren
Dilta-Hexal
Diltelan (TN)
Diltia
diltiazem
Diltiazem (INN)
Diltiazem [INN:BAN]
Diltiazem HCI
Diltiazem HCl
Diltiazem malate
diltiazem;Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Diltiazemum
Diltiazemum [INN-Latin]
Dilticard
Diltime (TN)
Diltzac
Dilzem
Dilzem (TN)
Dilzen
DR002508
DSSTox_CID_2940
DSSTox_GSID_22940
DSSTox_RID_76797
DTXSID9022940
Dyalec (TN)
EE92BBP03H
EINECS 255-796-4
Endrydil
Filazem (TN)
FT-0081415
FT-0625016
GTPL2298
HE342782
Herben (TN)
HMS1791B13
HMS1989B13
HMS2089H09
HSDB 6528
HSUGRBWQSSZJOP-RTWAWAEBSA-N
Incoril AP
l-Diltiazem
Lopac0_000327
LS-40510
MCULE-9931403933
MK-793 (Malate)
MolPort-002-509-369
NCGC00024309-02
NCGC00024309-04
NCGC00024309-05
NCGC00024309-06
NCGC00024309-07
NCGC00024309-08
NCGC00024309-09
NCGC00024309-10
NCGC00024309-11
NCGC00024309-17
Nu-Diltiaz
Prestwick0_000134
Prestwick1_000134
Prestwick2_000134
Prestwick3_000134
Progor (TN)
RG 83606 (Hydrochloride)
RG-83606
SC-16185
SCHEMBL17776
SPBio_002147
STOCK1N-03672
Surazem (TN)
Tiamate
Tiamate (TN)
Tiazac
Tiazac (TN)
Tiazac Tildiem
Tiazac XC
Tiazac XC (TN)
Tildiem (TN)
Tocris-0685
Tox21_110898
Tox21_110898_1
UNII-EE92BBP03H
VA10739
Vasmulax (TN)
Viazem
Viazem (TN)
W-106274
Zandil (TN)
Zemtrial (TN)
ZINC621893

US Patents and Regulatory Information for DILT-CD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex DILT-CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076151-001 May 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex DILT-CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076151-004 May 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex DILT-CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076151-002 May 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex DILT-CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076151-003 May 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
Chinese Patent Office
UBS
Citi
Federal Trade Commission
Johnson and Johnson
Queensland Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.